Literature DB >> 23727123

Caenorhabditis elegans as a model for the screening of anthelminthic compounds: ultrastructural study of the effects of albendazole.

Viviane Sant'anna1, Rossiane C Vommaro, Wanderley de Souza.   

Abstract

This study investigated the effects of albendazole on the viability, morphology and ultrastructure of different life stages of Caenorhabditis elegans. The albendazole EC50 value after seven days of treatment was 18.43 μM. This concentration was very efficient against all the stages. Light and electron microscopy analysis showed damage to the body wall of the adults and larvae. An intense desquamation of the cuticle of larvae and of the surface of the eggs was observed, preventing their hatching and development. The main ultrastructural damage detected was the degeneration of the mitochondria in the noncontractile muscle of the body wall, which appeared as large vacuoles. This study reaffirmed the use of C. elegans as a screening system for compounds with potential anthelmintic activity and showed the effects of albendazole on the different life stages of these worms.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Albendazole; Caenorhabditis elegans; Ultrastructure

Mesh:

Substances:

Year:  2013        PMID: 23727123     DOI: 10.1016/j.exppara.2013.05.011

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  6 in total

1.  A new methodology for evaluation of nematode viability.

Authors:  Sebastião Rodrigo Ferreira; Tiago Antônio Oliveira Mendes; Lilian Lacerda Bueno; Jackson Victor de Araújo; Daniella Castanheira Bartholomeu; Ricardo Toshio Fujiwara
Journal:  Biomed Res Int       Date:  2015-03-19       Impact factor: 3.411

2.  Diisopropylphenyl-imidazole (DII): A new compound that exerts anthelmintic activity through novel molecular mechanisms.

Authors:  María Gabriela Blanco; María Soledad Vela Gurovic; Gustavo Fabián Silbestri; Andrés Garelli; Sebastián Giunti; Diego Rayes; María José De Rosa
Journal:  PLoS Negl Trop Dis       Date:  2018-12-17

3.  Novel coumarins active against Trypanosoma cruzi and toxicity assessment using the animal model Caenorhabditis elegans.

Authors:  Fabiana Gomes Nascimento Soares; Gabriela Göethel; Luciano Porto Kagami; Gustavo Machado das Neves; Elisa Sauer; Estefania Birriel; Javier Varela; Itamar Luís Gonçalves; Gilsane Von Poser; Mercedes González; Daniel Fábio Kawano; Fávero Reisdorfer Paula; Eduardo Borges de Melo; Solange Cristina Garcia; Hugo Cerecetto; Vera Lucia Eifler-Lima
Journal:  BMC Pharmacol Toxicol       Date:  2019-12-19       Impact factor: 2.483

4.  Anthelmintic potency of Rumex crispus L. extracts against Caenorhabditis elegans and non-targeted identification of the bioactive compounds.

Authors:  Oladayo Amed Idris; Olubunmi Abosede Wintola; Anthony Jide Afolayan
Journal:  Saudi J Biol Sci       Date:  2021-09-17       Impact factor: 4.219

5.  Novel High-Throughput Fluorescence-Based Assay for the Identification of Nematocidal Compounds That Target the Blood-Feeding Pathway.

Authors:  Anthony Marchand; Joyce W M Van Bree; Aya C Taki; Mati Moyat; Gerardo Turcatti; Marc Chambon; Adam Alexander Thil Smith; Rory Doolan; Robin B Gasser; Nicola Laraine Harris; Tiffany Bouchery
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-27

6.  Discovery of genomic intervals that underlie nematode responses to benzimidazoles.

Authors:  Mostafa Zamanian; Daniel E Cook; Stefan Zdraljevic; Shannon C Brady; Daehan Lee; Junho Lee; Erik C Andersen
Journal:  PLoS Negl Trop Dis       Date:  2018-03-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.